UniProtKB/Swiss-Prot Q15645: Variant p.Glu303Lys

Pachytene checkpoint protein 2 homolog
Gene: TRIP13
Feedback?

Variant information Variant position:

303 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

US The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Glutamate (E) to Lysine (K) at position 303 (E303K, p.Glu303Lys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and acidic (E) to large size and basic (K) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

In OZEMA9; uncertain significance. Any additional useful information about the variant.
Other resources:

Links to websites of interest for the variant.

Variant rs772834014 [ dbSNP | Ensembl ]

Sequence information Variant position:

303 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

432 The length of the canonical sequence.
Location on the sequence:

QIDQIKRHSNVVILTTSNIT E KIDVAFVDRADIKQYIGPPS The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         QIDQIKRHSNVVILTTSNITEKIDVAFVDRADIKQYIGPPS

                              QIDQIKRHCNVVILTTSNITERIDVAFVDRADIRQYIGPPS

Mouse                         QIDQIKRHSNVVILTTSNITEKIDVAFVDRADIKQYIGPPS

Rat                           QIDQIKRHSNVVILTTSNITEKIDVAFVDRADIKQYIGPPS

Pig                           QIDQIKRHSNVVILTTSNITERIDVAFVDRADIRQYVGPPS

Chicken                       QIDQIKRYPNVVILTTSNITEKIDMAFVDRADIKQYIGPPS

Xenopus tropicalis            QIDHIKRYPNVVILSTSNLTEKIDVAFTDRADIKQYIGPPS

Zebrafish                     QLDQIKRHPNVVILTTSNVTEKIDLAFVDRADIKQYIGPPS

Caenorhabditis elegans        QIDRIRRRDNVLILCTSNLESTLDKALVDRADIVKNVGQPS

Baker's yeast                 QLDRLKKYHNFLALATSNLLDSLDDAFVDRADGVFYVGNPT

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 432	Pachytene checkpoint protein 2 homolog
Alternative sequence	171 – 406	Missing. In isoform 2.
Beta strand	302 – 304

Literature citations
Bi-allelic missense pathogenic variants in TRIP13 cause female infertility characterized by oocyte maturation arrest.
Zhang Z.; Li B.; Fu J.; Li R.; Diao F.; Li C.; Chen B.; Du J.; Zhou Z.; Mu J.; Yan Z.; Wu L.; Liu S.; Wang W.; Zhao L.; Dong J.; He L.; Liang X.; Kuang Y.; Sun X.; Sang Q.; Wang L.;
Am. J. Hum. Genet. 107:15-23(2020)
Cited for: VARIANTS OZEMA9 ARG-26; GLN-173; VAL-198; MET-247 AND LYS-303; CHARACTERIZATION OF VARIANT OZEMA9 ARG-26; INVOLVEMENT IN OZEMA9;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.